Carlos Tirado

584 total citations
20 papers, 318 citations indexed

About

Carlos Tirado is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Carlos Tirado has authored 20 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Carlos Tirado's work include Opioid Use Disorder Treatment (10 papers), Substance Abuse Treatment and Outcomes (6 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Carlos Tirado is often cited by papers focused on Opioid Use Disorder Treatment (10 papers), Substance Abuse Treatment and Outcomes (6 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Carlos Tirado collaborates with scholars based in United States, Chile and Portugal. Carlos Tirado's co-authors include Kyle M. Kampman, Kevin G. Lynch, Charles P. O’Brien, Helen M. Pettinati, Thorne Sparkman, Charles A. Dackis, Thomas Clinch, Danesh Alam, David W. Oslin and Peter Gariti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Drug and Alcohol Dependence and Addictive Behaviors.

In The Last Decade

Carlos Tirado

19 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Tirado United States 9 114 102 81 69 60 20 318
Vítor S. Tardelli Brazil 10 84 0.7× 84 0.8× 65 0.8× 96 1.4× 60 1.0× 28 324
Britahny M. Baskin United States 6 84 0.7× 107 1.0× 41 0.5× 54 0.8× 25 0.4× 12 260
Emi Shufman Israel 9 94 0.8× 82 0.8× 56 0.7× 91 1.3× 83 1.4× 17 317
Marina Tsoy Russia 9 149 1.3× 208 2.0× 60 0.7× 114 1.7× 61 1.0× 9 482
Raj K. Kalapatapu United States 9 47 0.4× 68 0.7× 46 0.6× 63 0.9× 56 0.9× 31 281
Peter A. DeMaria United States 10 164 1.4× 116 1.1× 51 0.6× 115 1.7× 32 0.5× 20 401
Shird Schindler Austria 10 96 0.8× 65 0.6× 74 0.9× 110 1.6× 75 1.3× 12 397
Sidarth Wakhlu United States 5 97 0.9× 79 0.8× 42 0.5× 74 1.1× 203 3.4× 7 363
Felipe Castillo United States 10 103 0.9× 114 1.1× 34 0.4× 102 1.5× 21 0.3× 20 358
John Rodolico United States 10 79 0.7× 142 1.4× 63 0.8× 52 0.8× 18 0.3× 12 359

Countries citing papers authored by Carlos Tirado

Since Specialization
Citations

This map shows the geographic impact of Carlos Tirado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Tirado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Tirado more than expected).

Fields of papers citing papers by Carlos Tirado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Tirado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Tirado. The network helps show where Carlos Tirado may publish in the future.

Co-authorship network of co-authors of Carlos Tirado

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Tirado. A scholar is included among the top collaborators of Carlos Tirado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Tirado. Carlos Tirado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weimer, Melissa B., Amanda Devoto, Devan Kansagara, et al.. (2024). The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology. Journal of Addiction Medicine. 18(4). 366–372.
2.
Tirado, Carlos, et al.. (2022). Delivering transcutaneous auricular neurostimulation (tAN) to improve symptoms associated with opioid withdrawal: results from a prospective clinical trial. SHILAP Revista de lepidopterología. 8(1). 12–12. 7 indexed citations
3.
Hill, Lucas G., et al.. (2022). Description and Evaluation of a Pilot Advanced Pharmacy Practice Experience in Addiction Medicine. American Journal of Pharmaceutical Education. 87(1). ajpe8926–ajpe8926. 7 indexed citations
4.
Hill, Lucas G., et al.. (2021). Addiction Treatment Networks Cannot Withstand Acute Crises: Lessons from 2021 Winter Storm Uri in Texas. NAM Perspectives. 2021. 3 indexed citations
5.
6.
Tirado, Carlos, et al.. (2020). Lofexidine for acute opioid withdrawal: A clinical case series. Mental Health Clinician. 10(5). 259–263. 4 indexed citations
7.
Moriates, Christopher, et al.. (2019). The Role of Hospitalists in Treating Opioid Use Disorder. Journal of Addiction Medicine. 14(2). 178–178. 6 indexed citations
8.
Tirado, Carlos, et al.. (2019). A Revised Occupational Stress Measure for Popular Musicians: Pilot Test of Validity and Reliability. Medical Problems of Performing Artists. 34(2). 85–91. 8 indexed citations
9.
Fishman, Marc, et al.. (2018). Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial. Journal of Addiction Medicine. 13(3). 169–176. 43 indexed citations
10.
Gordon, Alan, Adi Jaffe, A. Thomas McLellan, et al.. (2017). How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings From an Expert Round Table Discussion. Journal of Addiction Medicine. 11(2). 145–153. 12 indexed citations
11.
12.
Walker, Robrina, et al.. (2014). Characteristics of Mexican and Mexican American Adolescents in Treatment for “Cheese” Heroin Use. Journal of Ethnicity in Substance Abuse. 13(3). 258–272. 4 indexed citations
13.
Zickmund, Susan, et al.. (2012). Perceived Barriers to Hepatitis C Therapy for Patients Receiving Opioid Agonist Treatment. Journal of Addiction Medicine. 6(3). 233–239. 13 indexed citations
14.
Maxwell, Jane Carlisle, et al.. (2012). Cheese: An old drug in a new wrapper. Drug and Alcohol Dependence. 126(1-2). 161–167. 7 indexed citations
15.
Brown, E. Sherwood, Carlos Tirado, Abu Minhajuddin, et al.. (2010). Association of Race and Ethnicity With Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. Journal of Ethnicity in Substance Abuse. 9(2). 106–114. 12 indexed citations
16.
Plebani, Jennifer G., Carlos Tirado, Helen M. Pettinati, et al.. (2009). Combined effects of alcohol and hepatitis C: A secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence. Addictive Behaviors. 35(2). 123–128. 6 indexed citations
17.
Tirado, Carlos, Marina Goldman, Kevin G. Lynch, Kyle M. Kampman, & Charles P. O’Brien. (2008). Atomoxetine for treatment of marijuana dependence: A report on the efficacy and high incidence of gastrointestinal adverse events in a pilot study. Drug and Alcohol Dependence. 94(1-3). 254–257. 29 indexed citations
18.
Kampman, Kyle M., Helen M. Pettinati, Kevin G. Lynch, et al.. (2007). A Double-Blind, Placebo-Controlled Pilot Trial of Quetiapine for the Treatment of Type A and Type B Alcoholism. Journal of Clinical Psychopharmacology. 27(4). 344–351. 70 indexed citations
19.
Kampman, Kyle M., Charles A. Dackis, Kevin G. Lynch, et al.. (2006). A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug and Alcohol Dependence. 85(2). 129–137. 67 indexed citations
20.
Barroso, Natalia, Elisabetta Leo, J Larrauri, et al.. (1999). [Non-immunoallergic hepatotoxicity due to mesalazine].. PubMed. 22(4). 176–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vítor S. Tardelli Breakdown of academic impact, for papers by Britahny M. Baskin Breakdown of academic impact, for papers by Emi Shufman Breakdown of academic impact, for papers by Marina Tsoy Breakdown of academic impact, for papers by Raj K. Kalapatapu Breakdown of academic impact, for papers by Peter A. DeMaria Breakdown of academic impact, for papers by Shird Schindler Breakdown of academic impact, for papers by Sidarth Wakhlu Breakdown of academic impact, for papers by Felipe Castillo Breakdown of academic impact, for papers by John Rodolico
Rankless by CCL
2026